News

Pharmaceutical Technology2h
ASCO25: Roche’s Itovebi combo reduces risk of death in breast cancer by 33%
In combination with Pfizer’s CDK4/6 inhibitor Ibrance (palbociclib) and anti-oestrogen drug Faslodex (fulvestrant), Itovebi ...
Pharmaceutical Technology4h
NICE endorses CSL Vifor’s sparsentan for IgA nephropathy in adults
The NICE has issued final draft guidance endorsing the use of CSL Vifor's Filspari (sparsentan) for primary IgA nephropathy.
Pharmaceutical Technology7h
FDA approves GSK’s Nucala to treat COPD
GSK has received approval from the US Food and Drug Administration (FDA) for its monoclonal antibody, Nucala (mepolizumab).
Pharmaceutical Technology6h
Obesity therapies and the multi-indication momentum: how industry is responding
The rise of GLP-1 agonist therapies has transformed obesity treatment, delivering unprecedented results and revealing their ...
Pharmaceutical Technology7h
Bayer’s Eylea set for longer treatment intervals to challenge Roche’s Vabysmo
An EMA committee has issued a positive opinion for a label extension that would allow six-month injection intervals for Eylea ...
Pharmaceutical Technology6h
Medicaid on a spit after Republicans’ budget bill passes House by single vote
The Trump administration’s budget reconciliation bill has passed the US House of Representatives by a wafer-thin single-vote ...
Pharmaceutical Technology9h
Aptar Digital to use AstraZeneca’s AI algorithms for CKD detection
Aptar Digital Health has signed a licensing agreement with AstraZeneca for detecting CKD using the latter’s AI-driven ...